Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,639 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low incidences of acute and chronic graft-versus-host disease after unrelated bone marrow transplantation with low-dose anti-T lymphocyte globulin.
Hatanaka K, Fuji S, Ikegame K, Kato R, Wake A, Hidaka M, Ito T, Inoue M, Nagatoshi Y, Takami A, Uike N, Sakamaki H, Yabe H, Morishima Y, Suzuki R, Atsuta Y, Fukuda T. Hatanaka K, et al. Among authors: ito t. Int J Hematol. 2012 Dec;96(6):773-80. doi: 10.1007/s12185-012-1209-4. Epub 2012 Nov 7. Int J Hematol. 2012. PMID: 23132596
Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia.
Atsuta Y, Suzuki R, Nagamura-Inoue T, Taniguchi S, Takahashi S, Kai S, Sakamaki H, Kouzai Y, Kasai M, Fukuda T, Azuma H, Takanashi M, Okamoto S, Tsuchida M, Kawa K, Morishima Y, Kodera Y, Kato S; Japan Cord Blood Bank Network. Atsuta Y, et al. Blood. 2009 Feb 19;113(8):1631-8. doi: 10.1182/blood-2008-03-147041. Epub 2008 Dec 22. Blood. 2009. PMID: 19104080 Free article. Clinical Trial.
Tandem autologous versus autologous/allogeneic transplantation for multiple myeloma: propensity score analysis.
Kawamura K, Ikeda T, Hagiwara S, Mori T, Shinagawa A, Nishiwaki K, Ohashi K, Kubonishi S, Fukuda T, Ito T, Tomita N, Ichinohe T, Kato K, Morishima Y, Atsuta Y, Sunami K, Kanda Y. Kawamura K, et al. Among authors: ito t. Leuk Lymphoma. 2016 Sep;57(9):2077-83. doi: 10.3109/10428194.2016.1154958. Epub 2016 Mar 9. Leuk Lymphoma. 2016. PMID: 26961137
A Safety and Efficacy Study of Medium-Dose Etoposide, Cyclophosphamide and Total Body Irradiation Conditioning Before Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia.
Shigematsu A, Ozawa Y, Onizuka M, Fujisawa S, Suzuki R, Atsuta Y, Hatanaka K, Masuko M, Ito T, Kobayashi N, Kato J, Miyamura K, Fukuda T, Morishima Y, Imamura M. Shigematsu A, et al. Among authors: ito t. Transplant Direct. 2015 Mar 13;1(2):e8. doi: 10.1097/TXD.0000000000000514. eCollection 2015 Mar. Transplant Direct. 2015. PMID: 27500214 Free PMC article.
A prospective multicenter study of unrelated bone marrow transplants using a reduced-intensity conditioning regimen with low-dose ATG-F.
Fuji S, Kim SW, Yano S, Hagiwara S, Nakamae H, Hidaka M, Ito T, Ohashi K, Hatanaka K, Takami A, Kurosawa S, Yamashita T, Yamaguchi T, Fukuda T. Fuji S, et al. Among authors: ito t. Bone Marrow Transplant. 2016 Mar;51(3):451-3. doi: 10.1038/bmt.2015.268. Epub 2015 Nov 9. Bone Marrow Transplant. 2016. PMID: 26551777 Clinical Trial. No abstract available.
CD34+-selected autologous peripheral blood stem cell transplantation conditioned with total body irradiation for malignant lymphoma: increased risk of infectious complications.
Maeda S, Kagami Y, Ogura M, Taji H, Suzuki R, Kondo E, Asakura S, Takeuchi T, Miura K, Ando M, Nakamura S, Ito T, Kinoshita T, Ueda R, Morishima Y. Maeda S, et al. Among authors: ito t. Int J Hematol. 2001 Aug;74(2):214-21. doi: 10.1007/BF02982008. Int J Hematol. 2001. PMID: 11594525 Clinical Trial.
A prospective dose-finding trial using a modified continual reassessment method for optimization of fludarabine plus melphalan conditioning for marrow transplantation from unrelated donors in patients with hematopoietic malignancies.
Terakura S, Atsuta Y, Sawa M, Ohashi H, Kato T, Nishiwaki S, Imahashi N, Yasuda T, Murata M, Miyamura K, Suzuki R, Naoe T, Ito T, Morishita Y; Nagoya Blood and Marrow Transplantation Group. Terakura S, et al. Among authors: ito t. Ann Oncol. 2011 Aug;22(8):1865-71. doi: 10.1093/annonc/mdq673. Epub 2011 Feb 2. Ann Oncol. 2011. PMID: 21289367 Free article. Clinical Trial.
Changing trends in prognostic factors for patients with multiple myeloma after autologous stem cell transplantation during the immunomodulator drug/proteasome inhibitor era.
Takamatsu H, Honda S, Miyamoto T, Yokoyama K, Hagiwara S, Ito T, Tomita N, Iida S, Iwasaki T, Sakamaki H, Suzuki R, Sunami K. Takamatsu H, et al. Among authors: ito t. Cancer Sci. 2015 Feb;106(2):179-85. doi: 10.1111/cas.12594. Epub 2015 Feb 6. Cancer Sci. 2015. PMID: 25530023 Free PMC article.
Phase I/II trial of cure-oriented high-dose chemoradiotherapy with transplantation of CD34+ peripheral blood stem cells purified by the immunomagnetic bead method for refractory hematological malignancies. Nagoya CD34+ PBSCT Study Group.
Ogura M, Kagami Y, Suzuki R, Miura K, Uehira K, Kurokawa T, Ito T, Kinoshita T, Emi N, Morishima Y, Kodera Y, Ueda R. Ogura M, et al. Among authors: ito t. Cancer Chemother Pharmacol. 1997;40 Suppl:S51-7. doi: 10.1007/s002800051062. Cancer Chemother Pharmacol. 1997. PMID: 9272135 Clinical Trial.
Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm.
Aoki T, Suzuki R, Kuwatsuka Y, Kako S, Fujimoto K, Taguchi J, Kondo T, Ohata K, Ito T, Kamoda Y, Fukuda T, Ichinohe T, Takeuchi K, Izutsu K, Suzumiya J. Aoki T, et al. Among authors: ito t. Blood. 2015 Jun 4;125(23):3559-62. doi: 10.1182/blood-2015-01-621268. Epub 2015 Apr 27. Blood. 2015. PMID: 25918345 Free article. Clinical Trial.
11,639 results
You have reached the last available page of results. Please see the User Guide for more information.